Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Index 287

electromagnetic (EM) fields,

207– 208 , 217–218, 220–221

embryonic myogenesis, 5

embryonic stem cells (ESCs),

7 –8

endothelial, 89 , 93– 95

engineered muscle, 13

engraftment, 15

enhancement factor, 186

explanted, 42 – 43

extracellular matrix, 2

extrusion-based

printing, 52

F

fabrication of Janus-colloidal

nanoparticles, 117

fabrication of Janus-colloidal

particles, 118

failure tests, 36

Fano resonance, 158

fatigue, 34

Fe 3 O 4 –TiO 2 magnetic nanohybrids,

134

fetal, 29

fetoscopic, 31

fluorescence imaging, 245

formation of the hybrid

nanostructures, 107

Fourier transform infrared

spectroscopy, 45

FRET

wavelength-dependent

quenching, 181

G

gel permeation chromatography,

43 , 45

Gustav Mie, 153

H

hematopoietic, 89 , 92– 94

hepatocyte, 83, 86– 87

heterogeneous growth of hybrid

species, 106

hybrid

bioprinting, 53

constructs, 54 – 55

hybrid nanocrystals, 132

hybrid nanomaterials, 105

hybrid nanostars, 137

hybrid with paramagnetic

nanoparticles or ion, 130

hydrophobic/hydrophilic character,

233

hydrophobic surfaces, 44

hypoxic

differentiation, 63

I

imaging, 104

imaging agents and therapeutic

drugs, 104

imaging and therapeutic

applications, 136

imaging contrast agents, 103

immune response, 9

immunolabeled

nanoparticles, 179

induced pluripotent stem cells

(iPSCs), 7 –8

inflammation, 32

inflammatory reactions, 44

inkjet-based

bioprinting, 51

internanoparticle coupling

interactions, 153

in vitro degradation, 44

in vivo oxidation, 44

b2815_Index.indd 287 10/10/2017 12:15:37 PM